| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| VAPOTHERM Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 53,65 | +0,34 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius Q3/2026 | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Quartalsergebnis
Fresenius Q3/2026 (News mit Zusatzmaterial)
04.11.2026 / 06:45 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| INTUITIVE SURGICAL | 399,25 | -0,99 % | ISRG Gains 7.8% in 6 Months: Will the Share Price Recovery Continue? | ||
| MEDTRONIC | 90,60 | -0,44 % | Medtronic: What Wild Hearts Reveal | Medtronic LINQ insertable cardiac monitors track animal heart activity worldwide, revealing insights into stress, survival, and what "normal" means across species. NORTHAMPTON, MA / ACCESS Newswire... ► Artikel lesen | |
| THERMO FISHER | 643,00 | -0,12 % | Thermo Fisher Scientific (TMO) Is Benefiting From More Than Healthcare Demand: Here's the Overlooked AI Connection | ||
| BECTON DICKINSON | 193,30 | +1,47 % | Becton, Dickinson And Company Q4 Profit Advances | WASHINGTON (dpa-AFX) - Becton, Dickinson and Company (BDX) released earnings for its fourth quarter that Increases, from the same period last yearThe company's bottom line totaled $696 million... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 39,340 | -1,77 % | S&P senkt Ausblick für Boston Scientific auf "Negativ" - Wachsender Druck im Kerngeschäft | ||
| DEXCOM | 72,00 | +0,28 % | Dexcom lädt die weltweite Diabetes-Community ein, ihre Geschichten im Rahmen der Kampagne "A Letter to Diabetes" zu teilen | Mainz (ots) - - An diesem Weltdiabetestag stellt Dexcom eine einfache Frage: Wenn Sie dem Diabetes etwas mitteilen könnten, was würden Sie sagen?- Mit Beiträgen aus der gesamten weltweiten Diabetes-Community... ► Artikel lesen | |
| RESMED | 209,80 | +0,05 % | Apple, ResMed und mehr Dividenden im global market - Ex-Tag 12.11.2026 | ||
| BAXTER | 23,000 | -2,75 % | Baxter International Stock: Analyst Estimates & Ratings | ||
| DAVITA | 162,80 | 0,00 % | DaVita auf der 8th Annual Wolfe Research Healthcare Conference: Nicht-Dialysegeschäft kompensiert Volumenschwäche | ||
| ATOSSA THERAPEUTICS | 1,950 | +1,04 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2027 Financial Results, Delivering First-ever Net Income Before Income Tax | Total revenue increased 28% for the quarter and 41% for the six months ended September 30, 2026 compared to same periods last yearU.S. revenue increased 93% for the quarter and 113% for the six months... ► Artikel lesen | |
| ZIMMER BIOMET | 96,66 | +0,52 % | Zimmer Biomet Q3 Profit Falls, Lifts FY26 Outlook | WASHINGTON (dpa-AFX) - Zimmer Biomet Holdings, Inc. (ZBH), a medical technology company, on Wednesday reported lower profit for the third quarter, compared with the prior year quarter. Further... ► Artikel lesen | |
| TANDEM DIABETES | 14,900 | -11,31 % | Tandem Diabetes Care names successor as CEO Sheridan retires | ||
| INSULET | 134,70 | +1,55 % | Insulet Q3 Net Income Rises; Issues FY26 Outlook | WASHINGTON (dpa-AFX) - Insulet (PODD) reported third quarter net income of $141.1 million, or $2.03 per diluted share, compared to $87.6 million, or $1.24 per diluted share, prior year. Adjusted... ► Artikel lesen |